Metraipolis › archive › dc_ff9728f2c190

Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern — Europe PMC PMID:42308256

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42308256
DOI
10.1371/journal.pcbi.1014394
License (as archived)
CC0-1.0
Archived
2026-10-06T09:24:24.281Z
SHA-256 of the archived text
dcfbf2d6a8a38198d608d8fc4d8a23a1be10b87b5140bc6efee4389261ed75a0
Stable URL of this page
https://metraipolis.com/documento/dc_ff9728f2c190

How to cite

Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern — Europe PMC PMID:42308256 — Europe PMC (en), https://europepmc.org/article/MED/42308256 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_ff9728f2c190 (Metraipolis archive dc_ff9728f2c190, sha256 dcfbf2d6a8a38198d608d8fc4d8a23a1be10b87b5140bc6efee4389261ed75a0)
BibTeX
@misc{dcff9728f2c190,
  title = {Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern — Europe PMC PMID:42308256},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42308256},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_ff9728f2c190; sha256 dcfbf2d6a8a38198d608d8fc4d8a23a1be10b87b5140bc6efee4389261ed75a0},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/42308256. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Modeling and predicting viral mutations before they emerge plays a crucial role in pandemic preparedness, enabling the early identification of emerging variants of concern (VOCs) and guiding timely updates to vaccines, diagnostic tests, and therapeutic strategies. However, existing machine learning models and large-scale experiments lose their predictive power as viral variants evolve further from the original strains in sequence space. Here, we present a scalable framework that integrates random forest and neural network machine learning models with targeted high-throughput experimentation to anticipate and evaluate emerging SARS-CoV-2 receptor-binding domain (RBD) variants. Using public datasets, we trained predictive models for binding to human Angiotensin-converting enzyme 2 (ACE2), RBD expression, and antibody escape, and refined these models through iterative integration of experimental data focused on over 200 variants derived from wild-type (WT) and Omicron strains. Through an indirect transfer learning approach, our machine learning models achieved high accuracy having correlation coefficients of up to 0.79 for antibody binding. The models were also generalizable across diverse antibody types including heavy-chain-only antibodies (HCAbs) by encoding complementarity-determining regions (CDRs) as input features. This dynamic approach enables rapid assessment of emerging variants, facilities prioritization of the therapeutic strategies, and supports a proactive, data-driven response to evolving viral threats.

Tema degli esploratori: scienze della vita e salute (ricerca Europe PMC «microbiology», solo open access).
Pubblicazione: PLoS computational biology, 2026 (prima pubblicazione 2026-06-17).
Identificativi: PMID 42308256 · PMCID PMC13274873 · DOI 10.1371/journal.pcbi.1014394.
Descrittori MeSH principali: Machine Learning; SARS-CoV-2.
Pagina: https://europepmc.org/article/MED/42308256 — https://doi.org/10.1371/journal.pcbi.1014394. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T08:23:29.431Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.